Weekly Paclitaxel Administered During a Twin Pregnancy for Recurrent Breast Cancer: Case Report and Review of the Literature
Articolo
Data di Pubblicazione:
2022
Citazione:
Weekly Paclitaxel Administered During a Twin Pregnancy for Recurrent Breast Cancer: Case Report and Review of the Literature / Girardelli, S., Rabaiotti, E., Mauro, F., Gentilini, O., Zucchinelli, P., Cioffi, R., Valsecchi, L., Mangili, G., Peccatori, F.A., Candiani, M.. - In: JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY. - ISSN 2156-5333. - 11:6(2022), pp. 632-636. [10.1089/jayao.2021.0181]
Abstract:
Although cancer treatment during single pregnancy has been standardized, how to manage cancer diagnosed during a multiple gestation is still unclear. Chemotherapy during pregnancy has shown to be safe, however, there are reports of increased risks of fetal complications such as intrauterine growth restriction and preterm birth. Also, how to best adjust this to the pharmacokinetic characteristics of a twin gestation has yet to be fully investigated. We report the case of an IVF twin pregnancy with a diagnosis of breast cancer recurrence shortly after conception, and how the pregnancy was managed to obtain optimal obstetric, maternal/oncological, and fetal outcomes.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Girardelli, S.; Rabaiotti, E.; Mauro, F.; Gentilini, O.; Zucchinelli, P.; Cioffi, R.; Valsecchi, L.; Mangili, G.; Peccatori, F. A.; Candiani, M.
Link alla scheda completa:
Pubblicato in: